Every few years, biologists studying aging update the list of 'Hallmarks of Aging'. The list changes slightly each time, but one item consistently reappears: Mitochondrial dysfunction. In the eyes of many researchers, this is not just another item on the list. It is the item that drives all the others. Because once the cellular power plant starts producing less energy and more toxins, every other system in the cell, from DNA repair to the immune system, begins to break down in its wake.
New research reported on Phys.org on May 7, 2026, under the title Study seeks to stave off mitochondrial dysfunction believed to cause aging, attempts to tackle the practical question: if we know mitochondria fail with age, what are we doing about it? In this article, we will review the active therapeutic directions in 2026, from Urolithin A to MitoQ, from NMN to PGC-1α stimulation, and ask the tough question: why, despite twenty years of research, do we still not have a single approved drug that directly treats mitochondrial aging in humans.
What is Mitochondrial Dysfunction
Every cell in the human body (except red blood cells) contains hundreds to thousands of mitochondria. They are our endosymbiotic ancestors, ancient bacteria that merged with eukaryotic cells about two billion years ago and became organelles. Their functions include:
- ATP production, the energy currency of the cell, through oxidative phosphorylation in the electron transport chain.
- Regulation of programmed cell death (apoptosis) via cytochrome C release.
- Synthesis of essential molecules, from heme to steroids.
- Intracellular signaling through ROS levels, calcium, and fatty acids.
- Maintaining redox balance, balancing energy production with the disposal of free radicals.
Mitochondrial dysfunction is not a single event. It is a cascade: less ATP, more ROS (free radicals), damaged mitochondrial DNA, swollen and inefficient mitochondria, and ultimately chronic inflammatory signaling that infects the entire tissue.
The Connection to Aging: A Mechanism of Cumulative Collapse
The importance of mitochondria to aging is based on several key observations:
1. Mitochondrial DNA is particularly vulnerable. Unlike nuclear DNA, mtDNA is directly exposed to free radicals produced just nanometers away in the electron transport chain. Over decades, mutations accumulate. By age 70, a significant percentage of cells exhibit heteroplasmy, a mix of normal and damaged mtDNA.
2. Decline in NAD+ impairs efficiency. NAD+ is a coenzyme required for the function of the electron transport chain and the activity of Sirtuins. NAD+ levels drop by about 50% by age 50. Less NAD+ = less ATP, less DNA repair, less normal signaling.
3. Mitophagy slows down. Mitophagy is the mechanism the cell uses to 'take out the trash', clearing damaged mitochondria and digesting them. With age, this process becomes slow and inefficient, and damaged mitochondria accumulate instead of being cleared.
4. Mitochondrial biogenesis declines. Every day, the body produces new mitochondria through a process governed by PGC-1α, a master regulator of mitochondrial biogenesis. With age, levels and expression of PGC-1α decrease, and fewer new mitochondria replace the old ones.
The cumulative result: tissue (especially muscle, brain, and heart) filled with damaged, less efficient mitochondria that produce more toxins. This is the molecular definition of 'aging'.
Current Evidence: Therapeutic Directions
Study 1: Urolithin A (Mitopure) from Nestle and Amazentis, 2022-2025
Urolithin A is a metabolite produced by our microbiome from ellagitannins (compounds found in pomegranates and walnuts). It activates specific mitophagy. A multi-center study on 88 elderly individuals taking 500-1000 mg of Urolithin A daily for 4 months showed a 12% improvement in leg muscle strength and a 17% increase in aerobic endurance. The trial, published in JAMA Network Open, was the first proof that muscle function in the elderly could be improved by enhancing mitochondrial quality. However, a lifespan extension study in humans does not yet exist.
Study 2: MitoQ, a Mitochondria-Targeted Antioxidant (University of Otago, New Zealand)
MitoQ is a derivative of CoQ10 engineered to penetrate directly into the mitochondria, where it can neutralize free radicals at their source. A study in Hypertension on 20 older participants showed a 42% improvement in endothelial function (blood vessel wall function) after 6 weeks of 20 mg daily. In 2025, pilot results in Alzheimer's disease were published showing a 30% slowing of cognitive decline in a small group. A Phase 3 study is underway.
Study 3: NR and NMN, Replenishing NAD+ Stores (Stanford, Washington)
Supplements that raise peripheral NAD+ levels have shown a 30-40% increase in blood NAD+ levels and modest improvements (around 5-10%) in several metabolic markers. However, as discussed in article 402, they come with a cancer warning: high NAD+ levels may fuel resistant cancer cells. The question of whether NAD+ replenishment is effective enough as an anti-aging treatment to justify the risk remains open.
Study 4: PGC-1α Stimulators, The Frontier
The search for a drug that activates PGC-1α (the main player in mitochondrial biogenesis) is the holy grail. Animals with overexpressed PGC-1α live more than 15% longer. Molecules in development include: ZLN005 (active in mouse studies), SR-18292 (treats diabetes in mice), and several new molecules from Altos Labs. None have entered Phase 2 in humans as of 2026.
Study 5: Exercise, The Only Drug That Definitely Works
If you want to increase PGC-1α and improve mitochondrial function, the only method with strong evidence in humans is exercise, especially HIIT training. A study from the Mayo Clinic on elderly individuals aged 65-80 showed that after 12 weeks of HIIT, mitochondrial gene expression in muscle increased by 69%, a level similar to that of 30-year-olds. No drug achieves this result.
What About Neurodegenerative Diseases?
Mitochondrial collapse is particularly relevant to Alzheimer's and Parkinson's. In Parkinson's disease, damage to the mitochondria of dopaminergic neurons is one of the earliest signs. In Alzheimer's disease, brain ATP levels decline years before clinical symptoms appear.
Consequently, new therapeutic directions in neurodegeneration focus on saving mitochondria. EPI-743, a mitochondria-targeted derivative of vitamin E, is in a trial for Parkinson's. In ALS, trials with edaravone and high-dose CoQ10 continue. None are yet effective enough to stop the disease, but they slow the rate.
Heart failure is also no longer seen merely as a 'weak pump' disease but as a disease of 'weak heart mitochondria'. Heart muscle is the tissue with the most mitochondria per cell, making it particularly sensitive to mitochondrial failure.
Should We Start Taking Mitochondrial Supplements?
It depends on how seriously you approach the matter:
Urolithin A (500 mg daily)
The best clinical evidence among supplements. Price: about $100-150 per month in the US, around 350-500 shekels in Israel. Long-term safety data (beyond 4 months) is still lacking. Reasonable for an older person with muscle weakness, less clear for a healthy 40-year-old.
MitoQ (10-20 mg daily)
Less clinically proven, but has a unique profile due to direct mitochondrial penetration. Price: $60-90 per month. Risk: Antioxidants that act with excessive potency may disrupt normal ROS signaling. An Aristotelian principle: too much of a good thing can be harmful.
NMN/NR
Sold everywhere, but the caution discussed in article 402 about NAD and cancer is relevant here. If you have a cancer risk factor, this supplement is not safe.
CoQ10
The most established, also the cheapest. Proven effective in rare genetic mitochondrial diseases, but its efficacy in 'normal' aging is limited. Still a reasonable option for someone taking statins (which reduce endogenous CoQ10).
What to Do Starting Today
- Add 2-3 HIIT sessions per week. 4 rounds of 4 minutes at high intensity, with 3 minutes of rest in between. This is the only method proven in humans to increase mitochondrial biogenesis.
- Incorporate intermittent fasting of 14-16 hours. Fasting activates mitophagy and naturally raises NAD+, without supplements.
- Eat foods rich in ellagitannins, pomegranates, walnuts, raspberries. The microbiome will convert them to Urolithin A in the body, without needing a supplement.
- Avoid prolonged extreme temperatures, but do short cold exposures (cold shower for 2-3 minutes). This activates UCP1 and improves mitochondrial activity in brown fat.
- Quality sleep is essential for mitochondrial turnover. During deep sleep, mitophagy goes into high gear. Poor sleep = accumulation of damaged mitochondria.
The Broader Perspective
The story of mitochondrial dysfunction and aging is a case study for an entire field. On one hand, we have solid biological consensus: every aging biologist agrees that mitochondria are central. On the other hand, we have an empty medicine cabinet: after 30 years of research, there is no approved drug that treats mitochondrial aging in humans.
The reason is twofold. First, mitochondria are a highly complex system, not a single molecule problem. Any attempt to fix them through a single molecule runs into their delicate balance. Second, 'aging' is not an FDA-approved medical indication. Drug companies cannot run a Phase 3 trial on 'aging' because there is no official endpoint. They must find a specific disease (Parkinson's, sarcopenia, heart failure), and these trials take years and billions.
In the meantime, the individual who wants to maintain their mitochondria must return to basics: exercise, quality nutrition, good sleep, and occasional fasting. These are the interventions with the strongest evidence base, and they are cheaper than any future supplement or drug. Until research matures into a real drug, the answer is to nurture your power plant with the tools we already have.
References:
Phys.org - Study seeks to stave off mitochondrial dysfunction believed to cause aging
💬 תגובות (0)
היו הראשונים להגיב על המאמר.